Brian M. Hahn

CIK 1589711 · SVP Finance, CFO · last filed 2024-06-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

18

Lifetime Open-Market Net

-$333.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRESCENT BIOPHARMA, INC. (GLYC) Delisted SVP Finance, CFO 70,643 $15.70 $1.11M -$333.8K 18 2024-06-20

Recent Filings · Page 2 of 2

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-01-22 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Grant (A) $0 EDGAR
2018-06-12 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Mixed −14,085 -$343.1K EDGAR
2018-01-12 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Grant (A) $0 EDGAR
2017-01-05 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Grant (A) $0 EDGAR
2016-01-11 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Grant (A) $0 EDGAR
2015-03-03 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Exer (M) +5,000 $5.6K EDGAR
2015-01-12 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Grant (A) $0 EDGAR
2014-01-13 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Grant (A) $0 EDGAR
Showing 1118 of 18
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.